Orange Book product · Generic (ANDA)
CEFUROXIME AXETIL
CEFUROXIME AXETIL
At a glance
Feb 05, 2008
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 05, 2008
18 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
CEFUROXIME AXETIL
Strength
EQ 125MG BASE/5ML
Dosage form
FOR SUSPENSION
Route
ORAL
TE code
Not listed
Application
ANDA 065323
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CEFUROXIME AXETIL
- 1994CEFTINBrand (NDA)
NDA 050672 · GLAXOSMITHKLINE
- 1987CEFTINBrand (NDA)
NDA 050605 · GLAXOSMITHKLINE
- 2010CEFUROXIME AXETILGeneric (ANDA)
ANDA 065496 · ALKEM LABS LTD
- 2008CEFUROXIME AXETILGeneric (ANDA)
ANDA 065359 · ANDA REPOSITORY
- 2006CEFUROXIME AXETILGeneric (ANDA)
ANDA 065308 · AUROBINDO PHARMA
- 2005CEFUROXIME AXETILGeneric (ANDA)
ANDA 065166 · CHARTWELL RX
- 2004CEFUROXIME AXETILGeneric (ANDA)
ANDA 065190 · ANI PHARMS
- 2003CEFUROXIME AXETILGeneric (ANDA)
ANDA 065126 · FOSUN PHARMA
- 2003CEFUROXIME AXETILGeneric (ANDA)
ANDA 065135 · LUPIN
- 2003CEFUROXIME AXETILGeneric (ANDA)
ANDA 065118 · SUN PHARM INDS LTD
- 2002CEFUROXIME AXETILGeneric (ANDA)
ANDA 065069 · APOTEX
- 2002CEFUROXIME AXETILGeneric (ANDA)
ANDA 065043 · RANBAXY LABS LTD
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
